Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Nijhawan Pardeep

Over the trailing 90 days, Nijhawan Pardeep (Director at Edesa Biotech, Inc.) bought $800K of stock in EDSA, per 4 SEC Form 4 transactions.

Role
Director
Companies
EDSA
Window
Trailing 90 days · 4 transactions · CIK 1777962
Net activity
+$800K ($800K bought · $0 sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
EDSAEdesa Biotech, Inc.4$800K$800K

Transactions (4)

DateSymbolTypeSharesValueDescription
2026-07-02EDSABuy3.4K$0Grant, award or other acquisition
2026-06-16EDSABuy153.6K$800KGrant, award or other acquisition
2026-06-01EDSABuy1.7K$0Grant, award or other acquisition
2026-05-27EDSABuy96.9K$0Grant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Nijhawan's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free